Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Neurobiol Dis ; 69: 32-42, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24844149

ABSTRACT

Alzheimer disease (AD) is associated with increased amyloidogenic processing of amyloid precursor protein (APP) to ß-amyloid peptides (Aß), cholinergic neuron loss with decreased choline acetyltransferase (ChAT) activity, and cognitive dysfunction. Both 69-kDa ChAT and 82-kDa ChAT are expressed in cholinergic neurons in human brain and spinal cord with 82-kDa ChAT localized predominantly to neuronal nuclei, suggesting potential alternative functional roles for the enzyme. By gene microarray analysis, we found that 82-kDa ChAT-expressing IMR32 neural cells have altered expression of genes involved in diverse cellular functions. Importantly, genes for several proteins that regulate APP processing along amyloidogenic and non-amyloidogenic pathways are differentially expressed in 82-kDa ChAT-containing cells. The predicted net effect based on observed changes in expression patterns of these genes would be decreased amyloidogenic APP processing with decreased Aß production. This functional outcome was verified experimentally as a significant decrease in BACE1 protein levels and activity and a concomitant reduction in the release of endogenous Aß1-42 from neurons cultured from brains of AD-model APP/PS1 transgenic mice. The expression of 82-kDa ChAT in neurons increased levels of GGA3, which is involved in trafficking BACE1 to lysosomes for degradation. shRNA-induced decreases in GGA3 protein levels attenuated the 82-kDa ChAT-mediated decreases in BACE1 protein and activity and Aß1-42 release. Evidence that 82-kDa ChAT can enhance GGA3 gene expression is shown by enhanced GGA3 gene promoter activity in SN56 neural cells expressing this ChAT protein. These studies indicate a novel relationship between cholinergic neurons and APP processing, with 82-kDa ChAT acting as a negative regulator of Aß production. This decreased formation of Aß could result in protection for cholinergic neurons, as well as protection of other cells in the vicinity that are sensitive to increased levels of Aß. Decreasing levels of 82-kDa ChAT due to increasing age or neurodegeneration could alter the balance towards increasing Aß production, with this potentiating the decline in function of cholinergic neurons.


Subject(s)
Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/metabolism , Choline O-Acetyltransferase/metabolism , Neurons/metabolism , Peptide Fragments/metabolism , Adaptor Proteins, Vesicular Transport/genetics , Adaptor Proteins, Vesicular Transport/metabolism , Amyloid Precursor Protein Secretases/metabolism , Amyloid beta-Protein Precursor/genetics , Animals , Aspartic Acid Endopeptidases/metabolism , Brain/metabolism , Cell Line, Tumor , Cell Nucleus/metabolism , Cells, Cultured , Cholinergic Neurons/metabolism , Gene Expression , HEK293 Cells , Humans , Mice, Transgenic , Microarray Analysis , Presenilin-1/genetics , Presenilin-1/metabolism , Promoter Regions, Genetic
2.
J Neurochem ; 117(3): 538-53, 2011 May.
Article in English | MEDLINE | ID: mdl-21352228

ABSTRACT

In Alzheimer's disease, the amyloid-ß peptide (Aß) interacts with distinct proteins at the cell surface to interfere with synaptic communication. Recent data have implicated the prion protein (PrP(C)) as a putative receptor for Aß. We show here that Aß oligomers signal in cells in a PrP(C)-dependent manner, as might be expected if Aß oligomers use PrP(C) as a receptor. Immunofluorescence, flow cytometry and cell surface protein biotinylation experiments indicated that treatment with Aß oligomers, but not monomers, increased the localization of PrP(C) at the cell surface in cell lines. These results were reproduced in hippocampal neuronal cultures by labeling cell surface PrP(C). In order to understand possible mechanisms involved with this effect of Aß oligomers, we used live cell confocal and total internal reflection microscopy in cell lines. Aß oligomers inhibited the constitutive endocytosis of PrP(C), but we also found that after Aß oligomer-treatment PrP(C) formed more clusters at the cell surface, suggesting the possibility of multiple effects of Aß oligomers. Our experiments show for the first time that Aß oligomers signal in a PrP(C)-dependent way and that they can affect PrP(C) trafficking, increasing its localization at the cell surface.


Subject(s)
Amyloid beta-Peptides/pharmacology , Cell Membrane/metabolism , Neurons/drug effects , Peptide Fragments/pharmacology , PrPC Proteins/metabolism , Analysis of Variance , Animals , Biotinylation/methods , Cell Membrane/drug effects , Cells, Cultured , Embryo, Mammalian , Flow Cytometry/methods , Green Fluorescent Proteins/genetics , Hippocampus/cytology , Humans , Mice , Microscopy, Confocal/methods , Mitogen-Activated Protein Kinase 3/metabolism , Neurons/cytology , Protein Transport/drug effects , Time Factors , Transfection , rab5 GTP-Binding Proteins/metabolism
3.
Pediatr Res ; 65(3): 301-6, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19033882

ABSTRACT

Reduced cerebral function after neonatal hypoxia-ischemia is an early indicator of hypoxic-ischemic encephalopathy. Near-infrared spectroscopy offers a clinically relevant means of detecting impaired cerebral metabolism from the measurement of the cerebral metabolic rate of oxygen (CMRO2). The purpose of this study was to determine the relationship between postinsult CMRO2 and duration of hypoxia-ischemia in piglets. Twelve piglets were subjected to randomly selected durations of hypoxia-ischemia (5-28 min) and five animals served as controls. Measurements of CMRO2 were taken before and for 24 h after hypoxia-ischemia. Histology was carried out in nine piglets (six insults, three controls) to estimate brain injury. In the first 4 h after the insult, average CMRO2 of the insult group was significantly depressed (33 +/- 3% reduction compared with controls) and by 8 h, a significant correlation developed, which persisted for the remainder of the study, between CMRO2 and the duration of ischemia. Histologic staining suggested little brain damage resulted from shorter insult durations and considerable damage from more prolonged insults. This study demonstrated that near-infrared spectroscopy could detect early changes in CMRO2 after hypoxia-ischemia for a range of insult severities and CMRO2 could be used to distinguish insult severity by 8 h after the insult.


Subject(s)
Cerebrum/metabolism , Hypoxia-Ischemia, Brain/diagnosis , Hypoxia-Ischemia, Brain/metabolism , Oxygen/metabolism , Spectroscopy, Near-Infrared/methods , Animals , Cerebrum/pathology , Sus scrofa , Time Factors
4.
Biochem Pharmacol ; 72(4): 437-45, 2006 Aug 14.
Article in English | MEDLINE | ID: mdl-16793023

ABSTRACT

Aberrant angiogenesis is an essential step for the progression of solid tumors. Thus anti-angiogenic therapy is one of the most promising approaches to control tumor growth. In this study, we examined the ability of 20(R)-ginsenoside Rg3 (Rg3), one of the active compounds present in ginseng root, to interfere with the various steps of angiogenesis. Rg3 was found to inhibit the proliferation of human umbilical vein endothelial cells (HUVEC) with an IC50 of 10 nM in Trypan blue exclusion assay. Rg3 (1-10(3) nM) also dose dependently suppressed the capillary tube formation of HUVEC on the Matrigel in the presence or absence of 20 ng/ml vascular endothelial growth factor (VEGF). The VEGF-induced chemoinvasion of HUVEC and ex vivo microvascular sprouting in rat aortic ring assay were both significantly attenuated by Rg3. In addition, Rg3 (150 and 600 nM) remarkably abolished the basic fibroblast growth factor (bFGF)-induced angiogenesis in an in vivo Matrigel plug assay. The Matrix metalloproteinases (MMPs), such as MMP-2 and MMP-9, which play an important role in the degradation of basement membrane in angiogenesis and tumor metastasis present in the culture supernatant of Rg3-treated aortic ring culture were found to decrease in their gelatinolytic activities. Taken together, these data underpin the anti-tumor property of Rg3 through its angiosuppressive activity.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Ginsenosides/pharmacology , Angiogenesis Inhibitors/administration & dosage , Angiogenesis Inhibitors/chemistry , Animals , Aorta/drug effects , Aorta/enzymology , Aorta/growth & development , Capillaries/drug effects , Capillaries/growth & development , Cell Proliferation/drug effects , Collagen , Dose-Response Relationship, Drug , Drug Combinations , Drug Screening Assays, Antitumor/methods , Endothelial Cells/cytology , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Ginsenosides/administration & dosage , Ginsenosides/chemistry , Humans , In Vitro Techniques , Injections, Subcutaneous , Laminin , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Mice , Mice, Inbred C57BL , Molecular Structure , Neovascularization, Physiologic/drug effects , Proteoglycans , Rats , Vascular Endothelial Growth Factors/pharmacology
5.
Life Sci ; 79(7): 665-73, 2006 Jul 10.
Article in English | MEDLINE | ID: mdl-16566946

ABSTRACT

Sinomenine is an alkaloid with pharmacological effects of anti-inflammation, anti-angiogenesis, anti-arthritis and immunosuppression. This study aimed to investigate the effect of sinomenine on gene expression of human synovial sarcoma cells (Hs701.T) activated by IL-1 beta. The proliferative effect of sinomenine was examined in the presence or absence of IL-1 beta by the [3H]-thymidine incorporation and MTT assay, respectively. Using DNA microarray technology and RT-PCR, the activating action of IL-1 beta and modulatory effect of sinomenine on Hs701.T were simultaneously determined. Results showed that IL-1 beta could stimulate the proliferation and gene expression of Hs701.T cells. Sinomenine could significantly inhibit proliferation of IL-1 beta-activated Hs701.T cells and suppress expression of 17 genes including IL-6, PlGF, Daxx, and HSP27. These genes were found to be important in tumor progression through the mediation of inflammation, cell adhesion, proliferation, apoptosis and angiogenesis. In conclusion, our study provides supplementary information for the further studies on the pharmacological effects of sinomenine acting on synovial sarcoma.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Interleukin-1/biosynthesis , Interleukin-1/genetics , Morphinans/pharmacology , Sarcoma/metabolism , Synovial Membrane/metabolism , Cell Division/drug effects , Cell Line, Tumor , Cell Survival/drug effects , DNA, Neoplasm/biosynthesis , Gene Expression/drug effects , Gene Expression Profiling , Humans , Oligonucleotide Array Sequence Analysis , Reverse Transcriptase Polymerase Chain Reaction
6.
Angiogenesis ; 8(3): 205-16, 2005.
Article in English | MEDLINE | ID: mdl-16328162

ABSTRACT

The major active constituents of ginseng are ginsenosides, and Rg(1) is a predominant compound of the total extract. Recent studies have demonstrated that Rg(1) can promote angiogenesis in vivo and in vitro. In this study, we used a DNA microarray technology to elucidate the mechanisms of action of Rg(1). We report that Rg(1) induces the proliferation of HUVECs, monitored using [(3)H]-thymidine incorporation and Trypan blue exclusion assays. Furthermore, Rg(1) (150-600 nM) also showed an enhanced tube forming inducing effect on the HUVEC. Rg(1) was also demonstrated to promote angiogenesis in an in vivo Matrigel plug assay, and increase endothelial sprouting in the ex vivo rat aorta ring assay. Differential gene expression profile of HUVEC following treatment with Rg(1) revealed the expression of genes related to cell adhesion, migration and cytoskeleton, including RhoA, RhoB, IQGAP1, CALM2, Vav2 and LAMA4. Our results suggest that Rg(1) can promote angiogenesis in multiple models, and this effect is partly due to the modulation of genes that are involved in the cytoskeletal dynamics, cell-cell adhesion and migration.


Subject(s)
Gene Expression Regulation/drug effects , Ginsenosides/metabolism , Neovascularization, Physiologic/physiology , Panax/chemistry , Cell Adhesion/drug effects , Cell Line , Collagen , Cytoskeletal Proteins/metabolism , DNA Primers , Drug Combinations , Ginsenosides/pharmacology , Humans , Laminin , Models, Biological , Neovascularization, Physiologic/drug effects , Oligonucleotide Array Sequence Analysis , Plant Extracts/metabolism , Plant Extracts/pharmacology , Proteoglycans , Reverse Transcriptase Polymerase Chain Reaction , Thymidine/metabolism , Tritium
7.
Br J Nutr ; 93(1): 21-9, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15705221

ABSTRACT

Si-Jun-Zi decoction (SJZD), a traditional Chinese herbal prescription, has been used clinically for treating patients with disorders of the digestive system. Previous studies indicated that the polysaccharides of SJZD (SJZPS) are the active components contributing towards its pharmacological effects in improving gastrointestinal function and immunity. However, the protective and restitutive effects on intestinal epithelial cells remain unknown. In the present study, SJZPS were first extracted and chemically characterized. Then their stimulatory and restitutive effects on intestinal epithelial cells (IEC-6 cells) were elicited by different in vitro models including migration of wounded IEC-6 cells and cell proliferation. Results indicated that SJZPS not only protects the cells against the harmful impairment of indomethacin but also enhances re-epithelialization of a wounded monolayer at an optimal dose of 100 mug/ml at 24 h incubation. To elucidate the modulatory effect of SJZPS on wounded IEC-6 cells at the molecular level, an oligonucleotide microarray was employed to study differential gene expression of SJZPS-treated IEC-6 cells and the candidate genes were validated by RT-PCR. There was increased expression of genes coding for ion channels and transporters, which are critical to cell migration and restoration of wounded intestinal cells, suggesting a possible mechanism for re-epithelialization. In conclusion, our data show for the first time that SJZPS can enhance intestinal restitution and protect against indomethacin-induced damage of intestinal epithelial cells. These findings provide new insight into the mechanism of action of a traditional Chinese herbal prescription, SJZD, in intestinal wound restitution.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Intestinal Mucosa/drug effects , Polysaccharides/pharmacology , Wound Healing/drug effects , Animals , Cell Line , Cell Movement/drug effects , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/chemistry , Gene Expression Profiling/methods , Gene Expression Regulation/drug effects , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Polysaccharides/chemistry , Rats , Reverse Transcriptase Polymerase Chain Reaction/methods , Wound Healing/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...